Cynthia Comella
Rush University Medical Center · Rush University Medical Center, 1725 West Harrison Street, Suite 755, Chicago, 60612 Illinois, USA
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Cynthia Comella as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 03:59 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT04871451 · Extension Study of ABP-19000 to Evaluate Safety and Efficacy of Repeat Treatments of ABP-450 in Cervical DystoniaAEON Biopharma, Inc. · completed · Cervical Dystonia · principal investigator
- Ph2NCT04849988 · A Phase 2 Study to Evaluate the Safety and Efficacy of ABP-450 in the Treatment of Cervical DystoniaAEON Biopharma, Inc. · completed · Cervical Dystonia · principal investigator
- Ph3NCT00407030 · IncobotulinumtoxinA (Xeomin) Versus Placebo in the Treatment of Cervical DystoniaMerz Pharmaceuticals GmbH · completed · Cervical Dystonia · study chair
Grants
NIH projects from RePORTER, fetched 2026-11-12 03:59 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 03:59 UTC. The ranking covers the 200 most relevant of 41 PubMed records, and a shared surname and initials can bring in a namesake. All 41 on PubMed
- Randomized, double-blind trial of glial cell line-derived neurotrophic factor (GDNF) in PD.Neurology · 2003653 citationsRCR 15.5
- Effect of High-Intensity Treadmill Exercise on Motor Symptoms in Patients With De Novo Parkinson Disease: A Phase 2 Randomized Clinical Trial.JAMA Neurol · 2018423 citationsRCR 21.7
- Rating scales for dystonia: a multicenter assessment.Mov Disord · 2003278 citationsRCR 9.0
- Safety and efficacy of NeuroBloc (botulinum toxin type B) in type A-resistant cervical dystonia.Neurology · 1999259 citationsRCR 10.3
- Sleep-related violence, injury, and REM sleep behavior disorder in Parkinson's disease.Neurology · 1998248 citationsRCR 8.4
- Safety and efficacy of NeuroBloc (botulinum toxin type B) in type A-responsive cervical dystonia.Neurology · 1999244 citationsRCR 9.9
- A two-year randomized controlled trial of progressive resistance exercise for Parkinson's disease.Mov Disord · 2013240 citationsRCR 10.1
- Comparison of botulinum toxin serotypes A and B for the treatment of cervical dystonia.Neurology · 2005165 citationsRCR 6.3
- 164 citationsRCR 5.3
- Efficacy and safety of botulinum type A toxin (Dysport) in cervical dystonia: results of the first US randomized, double-blind, placebo-controlled study.Mov Disord · 2005160 citationsRCR 5.9